Phase 2-ready biotech using AI to develop therapies for rare diseases.
Industry: Health Care
First Day Return: +73.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/22/2021 |
Offer Price | $18.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 24.2 |
Deal Size ($mm) | $436 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/15/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $436 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Salt Lake City, UT, United States |
Founded | 2013 |
Employees at IPO | 218 |
Website www.recursionpharma.com |